367 results on '"del Papa, Nicoletta"'
Search Results
52. Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19 infection
53. Autologous haematopoietic stem cell transplantation and other cellular therapy in multiple sclerosis and immune-mediated neurological diseases : updated guidelines and recommendations from the EBMT Autoimmune Diseases Working Party (ADWP) and the Joint Accreditation Committee of EBMT and ISCT (JACIE)
54. Belimumab may decrease flare rate and allow glucocorticoid withdrawal in lupus nephritis (including dialysis and transplanted patient)
55. The story of the murine antiendothelial monoclonal antibody BGM: From patients' bedside to laboratory bench and from animal models to patients
56. The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak
57. Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
58. Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients
59. Nailfold Videocapillaroscopy Is a Useful Tool to Recognize Definite Forms of Systemic Sclerosis and Idiopathic Inflammatory Myositis in Interstitial Lung Disease Patients
60. Quantification of Ground Glass Opacities Can Be Useful to Describe Disease Activity in Systemic Sclerosis
61. Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them?
62. Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis
63. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
64. BAG3 induces α‐SMA expression in human fibroblasts and its over‐expression correlates with poorer survival in fibrotic cancer patients.
65. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
66. Sjögrenʼs syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögrenʼs syndrome, derived from an analysis of a cohort of Italian patients
67. Bone Marrow Endothelial Progenitors are Defective in Systemic Sclerosis
68. Anti-Endothelial Cell Antibodies
69. Precocious Intima-Media Thickening in Patients With Primary Sjögrenʼs Syndrome
70. Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease
71. Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course
72. Circulating Endothelial Cells as a Marker of Ongoing Vascular Disease in Systemic Sclerosis
73. Antiendothelial Cell Antibodies (AECA): From a Laboratory Curiosity to Another Useful Autoantibody
74. List of Contributors
75. Autoantibodies to Fibroblasts Induce a Proadhesive and Proinflammatory Fibroblast Phenotype in Patients With Systemic Sclerosis
76. Introduction: Autoimmune vasculitis: A good clinical and basic exercise
77. Iloprost treatment in systemic sclerosis: comment on the concise communication by Tedeschi et al
78. Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations
79. Adipose-derived mesenchymal stromal/stem cells in systemic sclerosis: Alterations in function and beneficial effect on lung fibrosis are regulated by caveolin-1
80. Interstitial Lung Disease in patients with Polymyalgia Rheumatica: A case series
81. Improving Treatment Related Mortality over Time - Data from the Non-Observational Trial on Autologous Stem Cell Transplantation in Systemic Sclerosis By the EBMT Autoimmune Diseases Working Party (ADWP)
82. Thrombotic events in patients with systemic sclerosis treated with iloprost
83. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis
84. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies
85. Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis
86. The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis
87. Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice
88. State of the art in interstitial pneumonia with autoimmune features: a systematic review on retrospective studies and suggestions for further advances
89. Management of primary Sjögren’s syndrome: recent developments and new classification criteria
90. Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts
91. The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score
92. Phenotypical and Functional Characteristics of in Vitro-Expanded Adipose-Derived Mesenchymal Stromal Cells from Patients with Systematic Sclerosis
93. Adipose-Derived Cell Transplantation in Systemic Sclerosis: State of the Art and Future Perspectives
94. Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
95. EULAR Sjögren's syndrome disease activity index (ESSDAI) : a user guide
96. EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
97. EULAR Sjögren's syndrome disease activity index (ESSDAI):a user guide
98. From mechanisms of action to therapeutic application: A review on current therapeutic approaches and future directions in systemic sclerosis
99. Reply to J. Magalon et al.
100. Regional Implantation of Autologous Adipose Tissue-Derived Cells Induces a Prompt Healing of Long-Lasting Indolent Digital Ulcers in Patients with Systemic Sclerosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.